Navigation Links
TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
Date:9/10/2007

PHILADELPHIA, Sept. 10 /PRNewswire/ -- TrialCheck(R), the nation's premier searchable database for cancer clinical trials, debuts today at the American Cancer Society web site (http://www.cancer.org) and its 24-hour National Cancer Information Center (1-800-ACS-2345), giving millions of cancer patients quick access to clinical trial matches for their diagnosis and locale.

Developed by the Coalition of Cancer Cooperative Groups in 2001, TrialCheck uses a patient-centered approach to online clinical trials matching. Its disease-specific search filter guides users through a short query on a patient's type of cancer, treatment history and current condition (four to six questions). Its location-driven filter displays the search results by proximity to the user's zip code. As a result, users (patients and physicians) have tailored information on the thousands of nationally registered cancer clinical trials open and seeking patients in the United States.

The new TrialCheck service will give visitors to cancer.org the ability to pinpoint trials at specific providers near their desired locations. TrialCheck uses a simple, short questionnaire to provide accurate results and help patients identify appropriate clinical trials for their needs.

TrialCheck will also enable cancer.org users to link to trained clinical trial specialists at the Society's National Cancer Information Center directly from their TrialCheck search. Shared access enables Web visitors to get immediate assistance with their search, as well as guidance interpreting search results and help verifying hospitals and clinical practices where clinical trials are available.

All users receive a recap of their TrialCheck search in writing, sent via mail from the American Cancer Society. This packet of information, which includes summaries of protocols returned in search results, takes a critical step, facilitating communication between the patient and his or her physician to confirm whether the protocols that appeared in the search results are an appropriate treatment option. Patients can also save their searches and send them via email to themselves or others for their personal use.

Bridging the Clinical Trial Knowledge Gap

These combined features allow users to continue to bridge the gap between patients seeking treatment options through clinical trials and the researchers who provide those clinical trials.

Although cancer clinical trials offer access to state-of-the-art care - and the potential for the development of more effective cancer treatments - the vast majority of cancer patients are unaware that clinical trials are a treatment option. Yet, data from a study of cancer survivors conducted by the Coalition and Northwestern University found that most patients (87 percent) would have considered enrolling had they known about the option at the time of their diagnosis. The findings also showed that most (84 percent) of those survivors who did enroll in a clinical trial were encouraged by their physician to participate.

"The combined power of two leading cancer organizations can help bridge these serious gaps in cancer clinical trial awareness and participation," said Robert L. Comis, M.D., Coalition president and chairman. "The data clearly underscore that it is crucial that cancer patients - and their physicians - are aware of clinical trial availability. With this new TrialCheck service, we can work with the American Cancer Society to reverse these enrollment trends and give patients access to information that can inform and facilitate discussion with their physician."

"This new service will help the American Cancer Society put clinical trial information into the hands of patients," said Richard. C. Wender, M.D., national volunteer president of the American Cancer Society. "Making the information easy to access and providing it in a way that supports the discussion between patients and their physicians about clinical trials provides a wonderful tool to help link patients with the right trial for them. As a result, we'll accelerate our understanding of cancer."

Updating Trial Locations in Real Time

Real-time updates are a distinguishing feature of TrialCheck that will also benefit users. In 2006, the Coalition introduced a technology enhancement that imports location information upon receipt for Cooperative Group trials. Participating oncology practices and hospitals appear in a trial record in real time as they are federally approved to participate in that study; conversely, locations are removed in real time from the database record when the study is closed or no longer available at that site. With outdated location information a common problem among trial databases, real-time updates are a popular feature among TrialCheck users. While real-time updates currently apply only to Cooperative Group studies, the proprietary informatics platform developed for real-time updates is a possible model for the Coalition to replicate with other types of studies in the future (pharmaceutical and biotech companies, cancer centers offering their studies in multiple locations, and other government-sponsored studies).

Tracking Clinical Trial Trends

An innovative TrialCheck feature, TrialTracker, will capture a vivid picture of patients' clinical trial experiences, determining whether they took steps and ultimately were enrolled into a trial. For the first time, the American Cancer Society can gain an expansive view of cancer clinical trial activity generated from its services and patient support initiatives, tracking the experiences of patients individually and collectively. In addition to activity around the thousands of nationally registered cancer clinical trials open and seeking patients in the United States, the TrialTracker service will provide comprehensive reporting on demographics and insights into patient barriers to enrollment (i.e., physician unfamiliar with trials, location, personal concerns, etc.) that can inform the development of new clinical trial education programs.

About the Coalition of Cancer Cooperative Groups

http://www.CancerTrialsHelp.org, originating site for TrialCheck The Coalition of Cancer Cooperative Groups is a nonprofit charitable organization whose mission is to improve the quality of life and survival of cancer patients by increasing participation in cancer clinical trials.


'/>"/>
SOURCE Coalition of Cancer Cooperative Groups
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Protox Announces Positive Clinical Data from Prostate Cancer Study
6. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
7. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
8. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
9. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
10. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
11. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... 2016 Global Paclitaxel Market 2016 ... 12 companies and the Paclitaxel analysis in this study ... industry and its players. This is the ... details the current state of the industry while providing ... applications and industry chain structure. The Paclitaxel market analysis ...
(Date:5/23/2016)... May 23, 2016 According ... Share, Development, Growth and Demand Forecast to 2022 ... Other), by Application (Drug Discovery and Development, Proteomics, ... (Pharmaceuticals, Life Science and Biotechnology, Academic and Research ... Research, the global mass spectrometry market ...
(Date:5/23/2016)... , May 23, 2016 ... for detection of multiple diseases; ,Technology to be presented ... Yissum Research Development Company of the Hebrew ... into a research agreement with Aurum Ventures MKI, the technology ... development of a new diagnostic approach for early detection ...
Breaking Medicine Technology:
(Date:5/24/2016)... , ... May 24, 2016 , ... How to Write ... Raleigh, NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the major ... human error will ever be totally eliminated, many human performance problems can be prevented. ...
(Date:5/24/2016)... ... May 24, 2016 , ... Loma Linda University Health (LLUH) has officially broken ... Children’s Hospital. Over 3,000 people looked on as the shovels hit the dirt at ... slidehsow. , During the program, Richard H. Hart, MD, DrPH, president, LLUH, recapped ...
(Date:5/24/2016)... ... May 24, 2016 , ... Eggsurance, ... the official relaunch of its community and education hub for women considering fertility ... is to create a safe and welcoming place for women to find cycle ...
(Date:5/24/2016)... ... May 24, 2016 , ... Tuesday, May 24, Women's Excellence in Wellness, powered ... Young Living Essential Oils, taught by Patti Dolan, RYT, a Young Living Gold ... Flow is 6:30pm - 7:15pm followed by a small intro to the Oils that ...
(Date:5/24/2016)... ... May 24, 2016 , ... In light of recent heavy flooding in Houston, ... contaminated well water throughout the Houston area. , Heavy floodwaters have led to destroyed ... to contaminants. Residents may not even be aware of the contamination of their water ...
Breaking Medicine News(10 mins):